|
Volumn 892, Issue 1, 2001, Pages 94-101
|
The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK
|
Author keywords
Lamotrigine; Potassium channel; Sipatrigine; Two pore domain
|
Indexed keywords
ANTICONVULSIVE AGENT;
ARACHIDONIC ACID;
COMPLEMENTARY DNA;
LAMOTRIGINE;
MESSENGER RNA;
NEUROPROTECTIVE AGENT;
POTASSIUM CHANNEL;
SIPATRIGINE;
ANTICONVULSANT ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG MECHANISM;
HUMAN;
HYPERPOLARIZATION;
MEMBRANE CONDUCTANCE;
MEMBRANE CURRENT;
MEMBRANE STEADY POTENTIAL;
MOLECULAR CLONING;
NEUROPROTECTION;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
PROTEIN EXPRESSION;
SEQUENCE ANALYSIS;
TISSUE DISTRIBUTION;
AMINO ACID SEQUENCE;
ANIMALS;
BRAIN;
CELL LINE;
FEMALE;
HUMANS;
MALE;
MEMBRANE POTENTIALS;
MICE;
MOLECULAR SEQUENCE DATA;
NERVE TISSUE PROTEINS;
NEUROPROTECTIVE AGENTS;
OOCYTES;
PIPERAZINES;
POTASSIUM CHANNEL BLOCKERS;
POTASSIUM CHANNELS;
POTASSIUM CHANNELS, TANDEM PORE DOMAIN;
PYRIMIDINES;
RNA, MESSENGER;
SEQUENCE ALIGNMENT;
SEQUENCE HOMOLOGY, AMINO ACID;
TRANSFECTION;
XENOPUS LAEVIS;
|
EID: 0035895804
PISSN: 00068993
EISSN: None
Source Type: Journal
DOI: 10.1016/S0006-8993(00)03239-X Document Type: Article |
Times cited : (54)
|
References (18)
|